Since our previous results have shown that the downregulation of pos.cu.sig is closely related to the formation of the tumor immunosuppressive microenvironment in KIRC, we were very curious about the prognostic characteristics of the expression of FDX1 as a cuproptosis core gene in KIRC, and whether it is related to tumor immunotherapy. Here, FDX1 is linked to neoplasm.